Insider Trading Alert - EDR, MANT And OHI Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, May 19, 2014, 147 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $80.88 to $19,640,406.96.

Highlighted Stocks Traded by Insiders:

Education Realty (EDR) - FREE Research Report

Koester J Drew, who is Senior VP and CAO at Education Realty, sold 9,100 shares at $10.46 on May 19, 2014. Following this transaction, the Senior VP and CAO owned 39,411 shares meaning that the stake was reduced by 18.76% with the 9,100-share transaction.

The shares most recently traded at $10.58, up $0.12, or 1.09% since the insider transaction. Historical insider transactions for Education Realty go as follows:

  • 4-Week # shares bought: 40,000
  • 4-Week # shares sold: 5,650
  • 12-Week # shares bought: 40,000
  • 12-Week # shares sold: 5,650
  • 24-Week # shares bought: 40,000
  • 24-Week # shares sold: 5,650

The average volume for Education Realty has been 1.2 million shares per day over the past 30 days. Education Realty has a market cap of $1.2 billion and is part of the financial sector and real estate industry. Shares are up 20.18% year-to-date as of the close of trading on Monday.

Education Realty Trust, Inc., a real estate investment trust (REIT), develops, acquires, owns, and manages student housing communities located near university campuses in the United States. The stock currently has a dividend yield of 4.23%. The company has a P/E ratio of 96.0. Currently, there are 5 analysts who rate Education Realty a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on EDR - FREE

TheStreet Quant Ratings rates Education Realty as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, compelling growth in net income and notable return on equity. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and poor profit margins. Get the full Education Realty Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Mantech International (MANT) - FREE Research Report

Porter Stephen W, who is Director at Mantech International, sold 3,000 shares at $29.76 on May 19, 2014. Following this transaction, the Director owned 3,000 shares meaning that the stake was reduced by 50% with the 3,000-share transaction.

The shares most recently traded at $29.52, down $0.24, or 0.81% since the insider transaction. Historical insider transactions for Mantech International go as follows:

  • 4-Week # shares sold: 1,800
  • 12-Week # shares sold: 1,800
  • 24-Week # shares sold: 1,800

The average volume for Mantech International has been 307,600 shares per day over the past 30 days. Mantech International has a market cap of $717.2 million and is part of the technology sector and computer software & services industry. Shares are up 0.17% year-to-date as of the close of trading on Monday.

ManTech International Corporation provides technologies and solutions for mission-critical national security programs in the United States and internationally. The stock currently has a dividend yield of 2.82%. Currently, there is 1 analyst who rates Mantech International a buy, 2 analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MANT - FREE

TheStreet Quant Ratings rates Mantech International as a hold. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, good cash flow from operations and increase in stock price during the past year. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and poor profit margins. Get the full Mantech International Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Omega Healthcare Investors (OHI) - FREE Research Report

Crabill R Lee, who is Senior Vice President at Omega Healthcare Investors, sold 10,000 shares at $36.30 on May 19, 2014. Following this transaction, the Senior Vice President owned 69,056 shares meaning that the stake was reduced by 12.65% with the 10,000-share transaction.

Ritz Michael, who is Chief Accounting Officer at Omega Healthcare Investors, sold 2,500 shares at $36.50 on May 19, 2014. Following this transaction, the Chief Accounting Officer owned 7,722 shares meaning that the stake was reduced by 24.46% with the 2,500-share transaction.

The shares most recently traded at $36.60, up $0.10, or 0.27% since the insider transaction. Historical insider transactions for Omega Healthcare Investors go as follows:

  • 4-Week # shares bought: 32,424
  • 4-Week # shares sold: 5,000
  • 12-Week # shares bought: 32,424
  • 12-Week # shares sold: 25,000
  • 24-Week # shares bought: 32,424
  • 24-Week # shares sold: 25,000

The average volume for Omega Healthcare Investors has been 1.1 million shares per day over the past 30 days. Omega Healthcare Investors has a market cap of $4.6 billion and is part of the financial sector and real estate industry. Shares are up 22.48% year-to-date as of the close of trading on Monday.

Omega Healthcare Investors, Inc. is a real estate investment firm. The firm invests in the real estate markets of United States. It invests in healthcare facilities, primarily in long-term healthcare facilities in order to create its portfolio. Omega Healthcare Investors, Inc. The stock currently has a dividend yield of 5.55%. The company has a P/E ratio of 23.3. Currently, there is 1 analyst who rates Omega Healthcare Investors a buy, 2 analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OHI - FREE

TheStreet Quant Ratings rates Omega Healthcare Investors as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth, compelling growth in net income, expanding profit margins and notable return on equity. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Omega Healthcare Investors Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

U.S. Crude Oil Hits Fresh 3-Year Highs as Gasoline Heads to $3 a Gallon

U.S. Crude Oil Hits Fresh 3-Year Highs as Gasoline Heads to $3 a Gallon

Stocks Waver Amid Progress on U.S.-China Trade; Dow Slips

Stocks Waver Amid Progress on U.S.-China Trade; Dow Slips

Jim Cramer: Schlumberger Predicted the Rise in Oil Prices

Jim Cramer: Schlumberger Predicted the Rise in Oil Prices

Jim Cramer on Zillow's New Business: Buying and Selling Homes

Jim Cramer on Zillow's New Business: Buying and Selling Homes

Jim Cramer on the Markets: It's Natural to Have Some Profit Taking

Jim Cramer on the Markets: It's Natural to Have Some Profit Taking